nodes	percent_of_prediction	percent_of_DWPC	metapath
Frovatriptan—Toothache—Metformin—polycystic ovary syndrome	0.0186	0.0746	CcSEcCtD
Frovatriptan—Rigors—Metformin—polycystic ovary syndrome	0.0138	0.0556	CcSEcCtD
Frovatriptan—Chest discomfort—Metformin—polycystic ovary syndrome	0.0128	0.0513	CcSEcCtD
Frovatriptan—Ear pain—Metformin—polycystic ovary syndrome	0.00962	0.0386	CcSEcCtD
Frovatriptan—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.00841	0.0338	CcSEcCtD
Frovatriptan—Pain in extremity—Metformin—polycystic ovary syndrome	0.00821	0.033	CcSEcCtD
Frovatriptan—Migraine—Metformin—polycystic ovary syndrome	0.00808	0.0324	CcSEcCtD
Frovatriptan—Dehydration—Metformin—polycystic ovary syndrome	0.00763	0.0306	CcSEcCtD
Frovatriptan—Sweating increased—Metformin—polycystic ovary syndrome	0.00691	0.0277	CcSEcCtD
Frovatriptan—Bradycardia—Metformin—polycystic ovary syndrome	0.00578	0.0232	CcSEcCtD
Frovatriptan—Rhinitis—Metformin—polycystic ovary syndrome	0.00569	0.0229	CcSEcCtD
Frovatriptan—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00565	0.0227	CcSEcCtD
Frovatriptan—Flushing—Metformin—polycystic ovary syndrome	0.00527	0.0212	CcSEcCtD
Frovatriptan—Chills—Metformin—polycystic ovary syndrome	0.00509	0.0205	CcSEcCtD
Frovatriptan—Malnutrition—Metformin—polycystic ovary syndrome	0.00494	0.0198	CcSEcCtD
Frovatriptan—Flatulence—Metformin—polycystic ovary syndrome	0.00487	0.0196	CcSEcCtD
Frovatriptan—Dysgeusia—Metformin—polycystic ovary syndrome	0.00484	0.0194	CcSEcCtD
Frovatriptan—Muscle spasms—Metformin—polycystic ovary syndrome	0.00475	0.0191	CcSEcCtD
Frovatriptan—Tremor—Metformin—polycystic ovary syndrome	0.00463	0.0186	CcSEcCtD
Frovatriptan—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00459	0.0184	CcSEcCtD
Frovatriptan—Malaise—Metformin—polycystic ovary syndrome	0.00446	0.0179	CcSEcCtD
Frovatriptan—Syncope—Metformin—polycystic ovary syndrome	0.00443	0.0178	CcSEcCtD
Frovatriptan—Palpitations—Metformin—polycystic ovary syndrome	0.00437	0.0175	CcSEcCtD
Frovatriptan—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00434	0.0174	CcSEcCtD
Frovatriptan—Myalgia—Metformin—polycystic ovary syndrome	0.00421	0.0169	CcSEcCtD
Frovatriptan—Chest pain—Metformin—polycystic ovary syndrome	0.00421	0.0169	CcSEcCtD
Frovatriptan—Discomfort—Metformin—polycystic ovary syndrome	0.00416	0.0167	CcSEcCtD
Frovatriptan—Shock—Metformin—polycystic ovary syndrome	0.00397	0.0159	CcSEcCtD
Frovatriptan—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.0039	0.0157	CcSEcCtD
Frovatriptan—Anorexia—Metformin—polycystic ovary syndrome	0.00385	0.0154	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00368	0.0148	CcSEcCtD
Frovatriptan—Paraesthesia—Metformin—polycystic ovary syndrome	0.00362	0.0145	CcSEcCtD
Frovatriptan—Dyspnoea—Metformin—polycystic ovary syndrome	0.0036	0.0144	CcSEcCtD
Frovatriptan—Somnolence—Metformin—polycystic ovary syndrome	0.00359	0.0144	CcSEcCtD
Frovatriptan—Dyspepsia—Metformin—polycystic ovary syndrome	0.00355	0.0143	CcSEcCtD
Frovatriptan—Decreased appetite—Metformin—polycystic ovary syndrome	0.00351	0.0141	CcSEcCtD
Frovatriptan—Fatigue—Metformin—polycystic ovary syndrome	0.00348	0.014	CcSEcCtD
Frovatriptan—Constipation—Metformin—polycystic ovary syndrome	0.00345	0.0139	CcSEcCtD
Frovatriptan—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00332	0.0133	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.0033	0.0132	CcSEcCtD
Frovatriptan—Abdominal pain—Metformin—polycystic ovary syndrome	0.00319	0.0128	CcSEcCtD
Frovatriptan—Asthenia—Metformin—polycystic ovary syndrome	0.00289	0.0116	CcSEcCtD
Frovatriptan—Pruritus—Metformin—polycystic ovary syndrome	0.00285	0.0115	CcSEcCtD
Frovatriptan—Diarrhoea—Metformin—polycystic ovary syndrome	0.00276	0.0111	CcSEcCtD
Frovatriptan—Dizziness—Metformin—polycystic ovary syndrome	0.00267	0.0107	CcSEcCtD
Frovatriptan—Vomiting—Metformin—polycystic ovary syndrome	0.00256	0.0103	CcSEcCtD
Frovatriptan—Headache—Metformin—polycystic ovary syndrome	0.00253	0.0101	CcSEcCtD
Frovatriptan—Nausea—Metformin—polycystic ovary syndrome	0.0024	0.00962	CcSEcCtD
Frovatriptan—HTR1B—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000615	0.000819	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000605	0.000806	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000593	0.000789	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000591	0.000788	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000591	0.000788	CbGpPWpGaD
Frovatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000591	0.000787	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000588	0.000782	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.000585	0.000779	CbGpPWpGaD
Frovatriptan—CYP1A2—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000581	0.000774	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.00058	0.000773	CbGpPWpGaD
Frovatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000579	0.000771	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000575	0.000766	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.00057	0.000759	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.000563	0.000749	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—NPB—polycystic ovary syndrome	0.000561	0.000748	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000558	0.000744	CbGpPWpGaD
Frovatriptan—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—polycystic ovary syndrome	0.000557	0.000742	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.000556	0.000741	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000555	0.000739	CbGpPWpGaD
Frovatriptan—HTR1A—G alpha (i) signalling events—POMC—polycystic ovary syndrome	0.000555	0.000738	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.000544	0.000724	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000543	0.000723	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000541	0.00072	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.000538	0.000716	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.000531	0.000707	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000529	0.000705	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.000521	0.000694	CbGpPWpGaD
Frovatriptan—CYP1A2—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000514	0.000684	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.000511	0.000681	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000508	0.000676	CbGpPWpGaD
Frovatriptan—CYP1A2—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000507	0.000675	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—LHB—polycystic ovary syndrome	0.000505	0.000672	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000505	0.000672	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.000499	0.000664	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.000497	0.000662	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000496	0.00066	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000494	0.000658	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.000494	0.000657	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000492	0.000655	CbGpPWpGaD
Frovatriptan—HTR1A—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	0.000484	0.000644	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000482	0.000642	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000473	0.00063	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.00047	0.000626	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000469	0.000624	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000469	0.000624	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—FSHR—polycystic ovary syndrome	0.00046	0.000612	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000451	0.000601	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—FSHR—polycystic ovary syndrome	0.00045	0.000599	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR ligand binding—POMC—polycystic ovary syndrome	0.00045	0.000599	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000448	0.000597	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000447	0.000595	CbGpPWpGaD
Frovatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000441	0.000587	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000441	0.000587	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000438	0.000584	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000438	0.000583	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000432	0.000576	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000425	0.000567	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000423	0.000564	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.00042	0.00056	CbGpPWpGaD
Frovatriptan—CYP1A2—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000414	0.000552	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000414	0.000551	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000412	0.000548	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—FST—polycystic ovary syndrome	0.00041	0.000546	CbGpPWpGaD
Frovatriptan—CYP1A2—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000409	0.000544	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000407	0.000543	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000405	0.000539	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000403	0.000537	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—FST—polycystic ovary syndrome	0.000401	0.000534	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—LHB—polycystic ovary syndrome	0.0004	0.000533	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000399	0.000531	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000396	0.000528	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—LHB—polycystic ovary syndrome	0.000392	0.000521	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000391	0.000521	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000383	0.00051	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000381	0.000508	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000379	0.000504	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000378	0.000503	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000377	0.000501	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—SCT—polycystic ovary syndrome	0.000375	0.000499	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000371	0.000494	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.00037	0.000493	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.00037	0.000493	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000367	0.000489	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—SCT—polycystic ovary syndrome	0.000367	0.000489	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—NMNAT3—polycystic ovary syndrome	0.000364	0.000485	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000362	0.000482	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000358	0.000476	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000351	0.000468	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.00035	0.000466	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000348	0.000464	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000348	0.000463	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000344	0.000458	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000343	0.000457	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000343	0.000457	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000341	0.000454	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.00034	0.000452	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000336	0.000447	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000336	0.000447	CbGpPWpGaD
Frovatriptan—HTR1A—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000334	0.000445	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000333	0.000444	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—LPCAT2—polycystic ovary syndrome	0.000333	0.000444	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—SUOX—polycystic ovary syndrome	0.000333	0.000444	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000329	0.000438	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000325	0.000433	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000322	0.000429	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000321	0.000427	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000318	0.000424	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000314	0.000418	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000314	0.000418	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ISYNA1—polycystic ovary syndrome	0.00031	0.000413	CbGpPWpGaD
Frovatriptan—CYP1A2—Biological oxidations—POMC—polycystic ovary syndrome	0.000309	0.000411	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—INSR—polycystic ovary syndrome	0.000307	0.000408	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—FST—polycystic ovary syndrome	0.000306	0.000407	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000304	0.000405	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000303	0.000403	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000302	0.000402	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—INSR—polycystic ovary syndrome	0.0003	0.0004	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—LHB—polycystic ovary syndrome	0.000298	0.000397	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000292	0.000388	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000291	0.000388	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000287	0.000382	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000285	0.00038	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PGR—polycystic ovary syndrome	0.000284	0.000378	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000283	0.000376	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000282	0.000376	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000282	0.000375	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000281	0.000374	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—SCT—polycystic ovary syndrome	0.00028	0.000372	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PGR—polycystic ovary syndrome	0.000278	0.00037	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000276	0.000367	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000268	0.000357	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000267	0.000355	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000264	0.000352	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000264	0.000352	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—TEAD2—polycystic ovary syndrome	0.000263	0.000351	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—AKR1C2—polycystic ovary syndrome	0.000263	0.000351	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000262	0.000349	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—RBP4—polycystic ovary syndrome	0.00026	0.000346	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000259	0.000344	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000259	0.000344	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000256	0.000341	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000254	0.000339	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000253	0.000337	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000252	0.000335	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000249	0.000332	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000249	0.000332	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000247	0.000328	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000246	0.000327	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000245	0.000326	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000243	0.000323	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000241	0.00032	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000239	0.000319	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000239	0.000319	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000232	0.00031	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000231	0.000308	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PRL—polycystic ovary syndrome	0.00023	0.000307	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—INSR—polycystic ovary syndrome	0.000229	0.000305	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000228	0.000303	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000226	0.000301	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PRL—polycystic ovary syndrome	0.000226	0.0003	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000222	0.000296	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PNPLA2—polycystic ovary syndrome	0.000221	0.000294	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000219	0.000291	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000217	0.00029	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000217	0.000289	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000214	0.000285	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000214	0.000285	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PGR—polycystic ovary syndrome	0.000212	0.000282	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—SRD5A1—polycystic ovary syndrome	0.000209	0.000279	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000203	0.00027	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—STAR—polycystic ovary syndrome	0.0002	0.000266	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000198	0.000264	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000197	0.000263	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000197	0.000262	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000197	0.000262	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000193	0.000257	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.00019	0.000253	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—NRG1—polycystic ovary syndrome	0.00019	0.000252	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000189	0.000252	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000188	0.00025	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000186	0.000247	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000183	0.000244	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000182	0.000243	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—HMMR—polycystic ovary syndrome	0.000178	0.000237	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000173	0.000231	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000172	0.000229	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PRL—polycystic ovary syndrome	0.000172	0.000229	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—HSD3B1—polycystic ovary syndrome	0.00017	0.000226	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000168	0.000223	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000166	0.000221	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000163	0.000217	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000162	0.000216	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000159	0.000212	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000159	0.000212	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—LEP—polycystic ovary syndrome	0.000159	0.000212	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—LEP—polycystic ovary syndrome	0.000156	0.000207	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—LHB—polycystic ovary syndrome	0.000155	0.000206	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—HSD3B2—polycystic ovary syndrome	0.000151	0.000201	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000151	0.000201	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—AKR1C1—polycystic ovary syndrome	0.000147	0.000195	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000144	0.000192	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000142	0.000189	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000141	0.000188	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000139	0.000185	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—POMC—polycystic ovary syndrome	0.000136	0.000182	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—INS—polycystic ovary syndrome	0.000136	0.000181	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—SULT2A1—polycystic ovary syndrome	0.000135	0.00018	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—POMC—polycystic ovary syndrome	0.000134	0.000178	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—INS—polycystic ovary syndrome	0.000133	0.000177	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000131	0.000175	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000131	0.000175	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—RRM2—polycystic ovary syndrome	0.000131	0.000174	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000129	0.000171	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000128	0.000171	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—YAP1—polycystic ovary syndrome	0.000126	0.000168	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000125	0.000166	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000122	0.000163	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000121	0.000161	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—NAMPT—polycystic ovary syndrome	0.000121	0.000161	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.00012	0.00016	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CYP11A1—polycystic ovary syndrome	0.000119	0.000159	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000119	0.000158	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—LEP—polycystic ovary syndrome	0.000118	0.000158	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—AKR1C3—polycystic ovary syndrome	0.000113	0.00015	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	0.000111	0.000148	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000106	0.000141	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—POMC—polycystic ovary syndrome	0.000102	0.000136	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—INS—polycystic ovary syndrome	0.000101	0.000135	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—IL6—polycystic ovary syndrome	0.0001	0.000134	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—IL6—polycystic ovary syndrome	9.83e-05	0.000131	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—IGF1—polycystic ovary syndrome	9.79e-05	0.00013	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—AKT2—polycystic ovary syndrome	9.78e-05	0.00013	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—TH—polycystic ovary syndrome	9.61e-05	0.000128	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	9.35e-05	0.000124	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	9.3e-05	0.000124	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	8.79e-05	0.000117	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—VEGFA—polycystic ovary syndrome	8.57e-05	0.000114	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—VEGFA—polycystic ovary syndrome	8.39e-05	0.000112	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	7.84e-05	0.000104	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—IL6—polycystic ovary syndrome	7.49e-05	9.97e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	7.47e-05	9.95e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	7.08e-05	9.43e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	6.6e-05	8.79e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—VEGFA—polycystic ovary syndrome	6.4e-05	8.52e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—IL6—polycystic ovary syndrome	5.93e-05	7.9e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—IL6—polycystic ovary syndrome	5.81e-05	7.73e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	5.36e-05	7.13e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	5.28e-05	7.03e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—INS—polycystic ovary syndrome	5.25e-05	6.99e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—IL6—polycystic ovary syndrome	4.42e-05	5.89e-05	CbGpPWpGaD
